Pane wikiwiki
How expanded genetic codes reshape ncAA selection, peptide library design, conjugation strategy and the sequence fidelity controls that prove what you buil
He aha nā code Genetic i hoʻonui ʻia no ka hoʻolālā peptide maʻamau

Hāʻawi ke code genetic maʻamau 64 codons: 61 sense codons a 3 hoʻopaʻa codons, a ʻo kēlā me kēia ʻano codon e kuhikuhi i kekahi o nā 20 canonical amino acids (ʻO Addgene Genetic Code Expansion ohi, loiloi hope loa 19 Nowemapa 2025). Hoʻonui hou ʻia ke code genetic i kēlā hana. Hoʻokahi a ʻoi aʻe nā codon e hoʻihoʻi ʻia i kahi amino acid noncanonical ma o ka codon reassignment, i hoʻokomo ʻia i ka paena e kahi tRNA orthogonal / aminoacyl-tRNA synthetase pair e hoʻopiʻi wale ana i kāna tRNA i hana ʻia a ʻaʻohe mea ʻē aʻe i ka host..

ʻOi aku ka liʻiliʻi o kēlā wehewehe ʻana ma mua o ke ʻano hemahema i laka ʻia. Amber (UAG) heluhelu ʻia ka hoʻopaʻa ʻana ma o kahi codon kū, no laila hoʻokūkū pololei me ka mea hoʻokuʻu 1. I ka wā e pio ai kēlā lāhui, ʻO ka hopena ka hoʻopau mua ʻana a me ka huahana ʻoki ʻia, ʻO kahi poho i hoʻololi hou ʻia a i ʻole RF1-knockout host i hoʻolālā ʻia e hōʻemi (Nature Biotechnology, 11 Kepakemapa 2024). ʻAʻole ʻokoʻa ka hoʻololi ʻana i ka Sense-codon: ke hoʻokūkū nei ka codon i kau hou ʻia me kona ʻano kumu, no laila hiki mai ka huahana ma ke ʻano he hui pū me nā canonical misincorporant ma mua o kahi kaulahao pōkole.
Ki Takeaway: ʻAʻole hiki ke hoʻopau ʻia ka Amber ma ka ʻoki ʻana; ʻAʻole hiki ke hoʻololi i ka sense-codon e ka hui ʻana. No laila, neʻe kaʻawale ka hua a me ka maʻemaʻe, a ua hoʻonohonoho ʻia ke ʻano hemahema āu e hoʻoili ai e ka hoʻolālā codon āu e koho ai, ʻaʻole ma muli o ke akamai o ka mea hoʻolako.
[DIAGRAM: ka papaʻaina 64-codon me UAG a hoʻokahi manaʻo codon i hōʻike ʻia, ua pana kēlā me kēia i kāna hui tRNA orthogonal/synthetase]

No ke aha i neʻe wikiwiki ai ka pahu hana ma mua o nā loiloi
ʻO ka mea kuhikuhi i ka hapa nui o nā hui e loaʻa i nā lag i ka kemika. A 2025 Hoʻopau ka loiloi i ka helu 300 hoʻohana maikaʻi ʻia nā ʻakika amino noncanonical i ka hoʻonui code genetic (Nature Communications, 29 Kepakemapa 2025), ʻoiai ʻo ka loiloi i ʻike nui ʻia ma nā hopena hulina ma kēia kumuhana 2014. Ua ʻoi aku ka wikiwiki o nā kumuwaiwai pae plasmid: ʻO Addgene ka hoʻonui ʻana i ka papa inoa hōʻiliʻili GCE 150 synthetase plasmids a me 26 nā maʻi bacteria, me ka maʻiʻo i nānā hope ʻia ma 19 Nowemapa 2025 (Addgene). Inā ua kūkulu ʻia kāu papa inoa pōkole mai kahi loiloi ʻumi makahiki, e wehewehe ana i kahi pahu mea hana liʻiliʻi ma mua o ka mea e noho nei.
Pehea ka hoʻonui ʻia ʻana o nā code Genetic i hoʻololi hou i ke koho ʻana i ka ʻakika amino noncanonical
Hoʻonohonoho pū kēlā hoʻolālā codon i nā huaʻōlelo o ke koho ʻana i ka waikona amino noncanonical, kahi i koho pālua, ʻaʻole ke koena koho, ʻo ia ka palena paʻa. ʻEhā mau mea e hoʻoholo ai i ka pair tRNA-synthetase hiki iā ʻoe ke hoʻohana: kūpono ka substrate, hoʻolālā codon, mea hoʻokipa, a inā pono ʻoe e hoʻopaʻa i ʻoi aku ma mua o hoʻokahi ncAA i ka manawa hoʻokahi. E hana ma o lākou ma ia ʻano a nalowale ka hapa nui o ke kūʻokoʻa i ke koena.
ʻElua mau paepae e lanakila. ʻO ka Methanocaldococcus jannaschii ʻAe ʻo TyrRS/tRNA^Tyr i nā kaulahao ʻaoʻao like me tyrosine a me nā mea ʻala. ʻO ka pyrrolysyl-tRNA synthetase scaffold a me kāna mau ʻano like ʻole e lawe i nā koena like me ka lysine a me ka nui., a hoʻomanawanui i nā ʻano like ʻole. E hoʻomaopopo ʻo RF1 knockout kahi hoʻolālā hoʻokipa e hoʻokiʻekiʻe i ka hana hoʻopau, ʻaʻole ke kolu paʻa.
|
Nā lawelawe Hiʻona |
M. jannaschii TyrRS/tRNA^Tyr |
PylRS/tRNA^Pyl nā ʻano like ʻole |
|---|---|---|
|
Lapa o ka substrate |
Me he tyrosine, mea ʻala |
Like me Lysine, nui loa, ʻano like ʻole ka hoʻolālā |
|
Hoʻolālā Codon |
Amber (UAG) kaohi ana |
Amber, ʻōkela, a i ʻole ka hoʻololi ʻana i ka sense-codon |
|
Hoʻopili hoʻokipa |
E. coli, hū, nā pūpū mammalian |
E. coli, nā pūpū mammalian, ʻōnaehana kelepona ʻole |
|
ʻO ke kūpono hoʻohuihui |
kaupalena; ka hoʻomanawanui ʻana o ka substrate |
ʻOi aku ka maikaʻi i ka hoʻonui ʻana i nā hui orthogonal |
ʻO Multiplexing kahi e neʻe ai ke kahua. A 2024 ʻike ʻia ka hoʻolālā codon-compression 12 ʻO nā hui tRNA-synthetase orthogonal e like me ka hoʻonohonoho kumu waiwai GCE i ʻike ʻia, He mea nui inā makemake kāu hoʻolālā i ʻelua a ʻoi aku paha nā ncAA ʻokoʻa i hoʻokahi kaulahao.
A laila aia ka palena ma waena o ka mea hiki ke hoʻokomo i kahi ribosome a me ka SPPS wale nō. ʻO ka hoʻololi ʻana i nā kaulahao ʻaoʻao ma kahi iwi kuamoʻo α-amino-acid i kūpono i ka GCE.. nā ʻakika β-amino, a,nā koena i hoʻololi ʻia, i nā depsipeptides, a ʻaʻole nui nā koena N-methylated; he SPPS wale nō a i ʻole in vitro-wale nō. Inā noho kāu koena pahuhopu ma kēlā papa inoa, ʻaʻohe koho pālua e hoʻopakele iā ia.
Heluhelu 'ana i ka ho'opau 'ana me ka 'oia'i'o
ʻO ka hana hoʻopau ʻana he laulā, a ʻo ka laulā wale nō ke ʻano o kekahi mea me ke koʻikoʻi a me ka mea hoʻolaha i hoʻopili ʻia. Hāʻawi nā ʻōnaehana mua ma kahi o 10-20% no kahi codon amber hoʻokahi. ʻO nā ʻōnaehana i hoʻonui ʻia a hiki i ka 50-117% ma muli o ka pōʻaiapili, a me 76-104% i ka RF1-hoʻopau C321 kānana. Hōʻike kēlā mau kiʻi i nā kūkulu like ʻole, no laila ʻaʻole lākou he alapiʻi hiki iā ʻoe ke piʻi ma ke koho ʻana i ka helu kiʻekiʻe.
ʻAʻole like ka metric o ka hoʻohui ʻia ʻana me ka helu helu kokoke-cognate. Holo ka heluhelu heluhelu 1% ma Top10, pili ana 3% ma BL21, a hiki i 17% i MG1655, hiki i ke kiʻekiʻe 47.5% ma kahi kahua amber i hāʻawi ʻia i kahi kāʻei RF1 i holoi ʻia. Hoʻokahi ana i ka nui o ka ncAA āu e kau ai; ʻo nā mea ʻē aʻe e ana i ka nui o ka waikawa amino hewa āu e hoʻokomo ai me ia.
ʻO ka hopena kūpono: he kikoʻī i kapa ʻia he pākēneka wale nō, me ka inoa ole o ka mea nana i kakau, ʻaʻole ia he kikoʻī. E noi i nā mea ʻelua ma mua o kou ʻae ʻana i kahi helu kūpono.
Ka Hoʻolālā ʻana i nā Hale Waihona Puke Peptide me nā ʻAmina Amino ʻAʻole
Ke hoʻopaʻa ʻia ka pālua, ʻO ke kahua hōʻikeʻike āu e koho ai e hoʻonoho i ke kaupaku ma luna o nā ʻakika amino noncanonical e loaʻa i kāu waihona. ʻO ka hōʻike mRNA a me ka RaPID e noho kiʻekiʻe ma luna o ka hoʻomanawanui ncAA no ka mea e holo ana ka pōʻai holoʻokoʻa i loko o ka vitro: Hoʻopiʻi pololei ʻo flexizyme i ka tRNA, no laila, ʻaʻole pono ka ribosome e hoʻokūkū me kahi host synthetase, a ʻo nā koena i hoʻololi ʻia i ka iwi kuamoʻo e hoʻomau i ka pāʻani. Kūlana kiʻekiʻe ka hōʻike Ribosome akā pili i ka ʻōnaehana, mai ka hoʻololi ʻana o ke ahonui me ka lysate a me ka hoʻonohonoho hoʻokuʻu-factor. Hiki ke hana ʻia ka hōʻike Phage, no ka mea hiki i ka hōʻike phage ke lawe i nā koena noncanonical ma o ka amber-encoding helper phage, ʻoiai ke kāohi nei ka mīkini hoʻokipa i nā koena e ola. ʻO ka hōʻike hū ka mea kaohi loa o nā ʻehā.
He mea nui ke kūlana e like me ke kahua. Hoʻokaʻawale ʻia ka hoʻolālā ʻana o ka hoʻolālā ʻana i ka hoʻolālā ʻana o ka hoʻololi ʻana i ka ncAA honua: Hoʻokahi a liʻiliʻi paha nā wahi i wehewehe ʻia e kūpono i kahi ʻimi mīkini a i ʻole hoʻokahi lima conjugation a noho maʻalahi ke ʻike, ʻoiai ʻo ka hoʻololi ākea e kūpono i ke kūpaʻa a i ʻole nā pale pale-protease a ʻoi aku ka paʻakikī e hōʻoia i ke koena e ke koena..
Kahi e hui ai ka hoʻolālā hale waihona puke i ke koho ala

ʻAʻole hiki ke hana ʻia kahi waihona i kūkulu ʻia a puni kahi koena iwi kuamoʻo e ka hoʻonui code genetic, no laila, pono e hana pū ka hoʻoholo hōʻike a me ka hoʻoholo hana ma mua o ke kaʻina. ʻO ka uku paʻa ka mea e pono ai ka ʻae ʻana i kēlā kaohi. I hoʻokahi pūʻulu inhibitor, cyclic β2,3 koena i pana i ka serum hapalua o ke ola i hala 168 hola ma 37 °C i ka serum kanaka, kūʻē 4.6 hola no ka ʻano ʻano alanine e pili ana; a hiki i ka lua o ka scaffold ma ka hana hookahi 48 hola versus hale kūʻai 4.2 hola. N-methylation hoʻonui i ka proteinase-K paʻa mai 6 mau minuke a hiki i ka nui 110 mau minuke i kāna ʻike ponoʻī, a me D-amino-akika hoʻololi i ka hapalua o ke ola mai nā minuke a i nā hola i loko o lākou. ʻAʻohe o kēia mau helu i hoʻohālikelike i nā peptides ma ke ʻano he papa: pili kēlā me kēia i kāna scaffold a me kāna ho'āʻo. ʻO ka hopena kūpono he haiki a paʻa. Inā makemake kāu pahuhopu paʻa i ka hoʻololi iwi kuamoʻo, koho ʻia ke ala no ʻoe, a pono e hoʻolālā ʻia ka waihona i loko o kēlā palena mai ka hoʻomaka ʻana.
Paena-Specific Conjugation Strategies Enable by Expanded Codes
Lawe pololei kēlā hoʻoholo ala i ka conjugation, kahi e kūʻai aku ai kahi mea ncAA i ka mana kūlana ʻaʻole hiki ke hoʻohālikelike ʻia ke koena canonical, a hoʻololi i ke ʻano hāʻule ma mua o ka hoʻopau ʻana i ka hemahema. Hāʻawi kahi lāʻau bioorthogonal i hoʻonohonoho ʻia ma kahi kūlana i wehewehe ʻia i ka mana kūlana kiʻekiʻe loa a me ka haʻahaʻa haʻahaʻa haʻahaʻa haʻahaʻa o nā hoʻolālā conjugation peptide kikoʻī., akā, ʻo ka hāʻule ʻole āu e hoʻokele ai, ʻo ia ka hoʻohui piha ʻole ʻana a i ʻole nā mea hoʻomaka ʻole, ʻaʻole kuhi hewa. ʻO ka Cysteine he chemoselective a maʻalahi, ʻoi aku ka nui o ka alkylation, He mea maʻamau ka oxidation a me ka scrambling disulfide. Hāʻawi ka hui ʻana o Lysine i nā hui regioisomer. Hoʻomaikaʻi ka kemika N-terminal i ka lysine akā noho mau- a pili i ka pōʻaiapili.
|
Kemika |
koho koho |
Kinetics |
keleawe |
Hana ʻia ke ʻano hemahema |
|---|---|---|---|---|
|
SPAAC (azide + cyclooctyne) |
Kiʻekiʻe |
Kaumaha |
ʻAʻole koi ʻia |
ʻO ka lima azide i hana ʻole ʻia |
|
CuAAC (azide + alkyne) |
Kiʻekiʻe |
wikiwiki |
Pono |
Nā hopena ʻaoʻao i hoʻopaʻa ʻia i ke keleawe |
|
Tetrazine-TCO |
Hoʻohuihui Peptide Kiʻekiʻe |
ʻO ka wikiwiki loa |
ʻAʻole koi ʻia |
Hydrolysed tetrazine |
|
Electrophilic ncAA cyclization |
Kiʻekiʻe ke hoʻonohonoho mua ʻia ke geometry |
Intramolecular |
ʻAʻole koi ʻia |
Huahana intermolecular hoʻokūkū |
He pōkole ka papa kuhikuhi. He keleawe-noa ka SPAAC a maʻalahi ka hana; ʻO CuAAC ka mea ikaika loa akā ʻo ka ʻike keleawe ke kuleana; ʻO nā lepili tetrazine-TCO wikiwiki loa; a me ka electrophilic ncAA cyclization he intramolecular a maʻemaʻe ke hoʻonohonoho mua ʻia ke geometry, e like me ka mea i hoikeia no palua bio-orthogonal ncAA lima (Nature Communications, 2023).
Ke koho ʻana ma waena o Bioorthogonal Conjugation a me Native Chemical Ligation
Hoʻoponopono ka ligation kemika maoli a me ka conjugation ncAA i nā pilikia like ʻole a ʻaʻole ia he pani. ʻO NCL ke ala i ka wā e koi ai ka pahuhopu i kahi hoʻololi iwi kuamoʻo, he D-koena, a i ʻole kahi ʻāpana ʻaʻole e hoʻopiʻi ʻia e nā pālua orthogonal; ʻO kāna mea e pono ai he hui ligation kūpono a me kahi māhele thioester. ʻO ka conjugation ncAA ke ala inā he peptide α-backbone maʻamau ka pahuhopu e pono ai kahi wahi hoʻopili i wehewehe ʻia., a ʻo kāna mea e koi mua ai, ʻo ia ka mea e ʻae ana ka lau o ka substrate i ka paʻa a me kahi hoʻokipa a i ʻole ka unuhi e kāohi ana i ka heluhelu canonical hoʻokūkū..
ʻO ka hopena kūpono: e hoʻoholo i ka hoʻoholo conjugation i ka manawa like me ka hoʻoholo ncAA. ʻO kahi lima i koho ʻole ʻia e uku ʻia he hoʻolālā hou, aole he pani.
Nā Mana Analytical E Hōʻoiaʻiʻo i ka Pono Pono
ʻO kēlā me kēia ala conjugation āu e hoʻoholo ai, ʻO ka pūʻolo hoʻomalu ka mea e hoʻololi i kahi koi synthesis i kahi kikoʻī pale, a pono e hoʻolālā ʻia ma mua o ka hana ʻana i ka hailona mua, ʻaʻole i ʻākoakoa ʻia ma hope o ka haʻalele ʻana. No kēlā me kēia peptide e lawe ana i kahi koena noncanonical, ʻO nā mana analytical sequence fidelity e kau ma luna o ʻelima mau mea: ka hōʻoia ʻana o ka peptide paʻa a me ke kaʻina-localizing fragment ion e pili ana i ke koena i hoʻololi ʻia e LC-MS/MS; hoʻohuihui-efficiency quantitation, ʻo ia ka hapa o ka peptide e lawe ana i ka ncAA versus canonical misincorporants a i ʻole nā huahana i hōʻailona ʻole ʻia.; he mana diastereomer/epimer e kūʻē i kahi kuhikuhi synthetic a i ʻole kahi chiral orthogonal a i ʻole ke ʻano manawa paʻa., no ka mea, ʻaʻole hiki i ka LC-MS maʻamau ke hoʻokaʻawale i nā epimer; hōʻoia ʻōnaehana unuhi orthogonal me nā mana maikaʻi ʻole a ʻaʻole hiki ke ʻike ʻia ma waho o ka helu heluhelu; a, no nā ncAA i hōʻailona ʻia e like me ka selenium a i ʻole nā ʻano boron, ka nānā ʻana i ka waikawa amino a i ʻole ICP-MS (2026 loiloi e pili ana i ka bioconjugation pololei a me ka hoʻohui ʻana i ka pūnaewele, kiʻi ʻia 2026-02-04).
Hoʻonohonoho ʻana i ka ʻae ʻana ma mua o ka Lot Mua

Hiki ke hoʻohana ʻia kēlā me kēia mana i ka wā e lawe ana i kahi helu. E hoʻopaʻa i ka pololei nui i ke koena e hōʻoia ʻia, e hoʻopaʻa i ka paepae hoʻohui-efficiency i ka mana hoʻonā o ka assay e ana ana iā ia., a koi aku i ka mana epimer e inoa i ka maʻamau kuhikuhi e hoʻohālikelike ai. Ma kahi o ka peptide he moho makua, ʻO ka palena o ka lāʻau lapaʻau i loaʻa i ka dose: USP <85> kau i ka palena endotoxin = K/M, me K = 5 EU / kg / hola no nā ala komo ʻole a me K = 0.2 EU/kg/hola intrathecal, i hōʻike ʻia ma ka mg a i ʻole ka mL o ka nui o ke kanaka. I Q2(R2) hoʻonohonoho i nā ʻāpana hōʻoia, a me nā loina MHRA ALCOA i hoʻonohonoho i nā manaʻolana kūpaʻa ʻikepili a puni lākou.
ʻO kahi mana ʻaʻole i kākau ʻia i loko o ka kikoʻī ma mua o ka hailona mua he mana āu e kūkākūkā ai ma hope o kahi haʻalele..
Hoʻonui: SPSS, CFPS a me Lot-to-Lot Fidelity Risk
Pono kēlā mau mana e ola i ka scale-up, no ka mea, ʻo ke ala i hoʻopuka ai i kāu pūʻulu noiʻi ʻaʻole ia ke ala e hana ai i kāu pūʻulu lapaʻau, a ke hoʻololi nei ka ʻaoʻao pili pono me ia. Hoʻohana ʻia ka peptide synthesis solid-phase ma nā milligrams a i ka grams i kēlā me kēia pūʻulu, me nā kaʻina hana hoʻomākaukau a me ka ʻoihana e hiki ana i nā ʻumi a i nā haneli haneli, a me kekahi mau kaʻina i ka unahi kilo. Hāʻawi nā ʻōnaehana kelepona ʻole i ka mg i ka lita: pili ana 96 ± 3 mg/L no ka lawe pūmua 40 nā ʻakika amino like ʻole, ʻoiai ua hōʻea ʻia kahi ʻāpana hemahema RF1 maikaʻi loa 1,780 ± 30 mg/L no ka sfGFP (palapala hoʻohui pū me ka cell-free ncAA, 2020). He ʻoiaʻiʻo ka awāwa ma waena o ke kelepona ʻole a me ke ala paʻa, a hoʻohālike ia i ka manaʻo o ka hilinaʻi i kēlā me kēia pae.
ʻElua mau pōʻino o ka hailona mai kēlā māhele. Ma lalo o ke kaohi ʻana amber, ʻokoʻa nā huahana ʻoki a me ka heluhelu ʻana me ka mokuʻāina hoʻokipa, no laila hiki ke hoʻololi ka ʻaoʻao haumia ma waena o ka holo ʻana o ka fermentation inā ʻaʻole i hoʻololi ʻia ka pūʻali i hoʻopaʻa ʻia. Ma lalo o ka sense-codon reassignment, hiki ke ne'e ka ratio noncanonical-to-canonical oiai e palahalaha ana ka huina hua, 'o ia ho'i, 'a'ole e loa'a ka ho'ā'o ho'oku'u hua wale.
ʻO ka hopena kūpono: aia nā mana hoʻopono mai ka ʻāpana mua i ka wehewehe hoʻokuʻu no kēlā me kēia ʻāpana, ʻaʻole wale i ka pūʻulu hōʻoia.
He aha e nīnau ai i kahi hoa ma mua o ka hana ʻana
E lawe i ʻeono mau nīnau i ke kamaʻilio ʻana. ʻO ka waika amino noncanonical a me ka hui orthogonal? ʻO ka hoʻolālā codon, ka hoʻopau ʻana amber a i ʻole ka hoʻihoʻi ʻana i ka sense-codon? ʻO ka mea hoʻokipa a i ʻole ke kelepona ʻole, a he aha kāna hana hoʻopau ʻana i kākau ʻia? ʻO ke ala conjugation, a mālama i ke koena i hoʻohui ʻia? ʻO wai o nā mana hoʻopono ʻelima e holo ana ma kēlā me kēia ʻāpana? A he aha nā koina ʻae e wehewehe i ka hailona ma mua o ka hana ʻana o ka mea mua?
Kākoʻo ke kaʻina hana hoʻolālā-i-QC i kēia. Hiki ke hoʻohana ʻia nā hoʻololi MOL e hoʻohālikelike i ke koho ncAA, ala synthesis a me nā pae hoʻokuʻu analytical hoʻokuʻu i hoʻokahi lima, no laila, ʻo nā mana i ʻae ʻia ma ka pae hoʻolālā, ʻo ia nā mana e holo ma ka pālākiō. E noi i ka papa hoomalu pae hailona ma ke kakau ana, a hoʻohālikelike me kāu kikoʻī ponoʻī ma mua o ka hana ʻana.
Manaʻo kuhihewa maʻamau e pili ana i nā code Genetic i hoʻonui ʻia
Hōʻike pinepine ʻia nā hewa ʻehā i nā loiloi papahana e pono ai lākou e inoa pololei.
ʻO ka mea mua, ʻo ke code genetic i hoʻonui ʻia ʻo ia ka genome kākau hou ʻia. Ma ka hoʻomaʻamaʻa maʻamau ka manaʻo hoʻokahi codon i hoʻonoho hou ʻia a me hoʻokahi pālua orthogonal, hoʻohui ʻia i kahi pūʻali i hoʻololi ʻole ʻia.
ʻO ka lua, ʻo ka hoʻohui ʻana i ka maikaʻi ʻoi aku ka maʻemaʻe kiʻekiʻe. Hiki i nā mea ʻelua ke neʻe i nā ʻaoʻao ʻē aʻe: Hiki i ka sense-codon reassignment ke paʻa i ka hua i ka wā e hāʻule ai ka maʻemaʻe, no ka mea, ua loaʻa i kēia manawa ka codon i hoʻokaʻawale ʻia i nā tRNA kokoke-cognate a me ka hui orthogonal..
ʻO ke kolu, ʻo ia ka hiki ke hoʻokomo ʻia kekahi amino acid noncanonical i kekahi ala hana. ʻO ka māhele hoʻololi iwi kuamoʻo he palena paakiki, ʻaʻole he makemake: ʻAʻole hiki ke hoʻokomo ʻia nā koena e hoʻololi i ka iwi kuamoʻo e ka hoʻohui ʻana o ribosomal, a ʻaʻole hiki ke hana ʻia nā koena e koi ana i ka ribosome e SPPS.
ʻO ka hā e pili ana i ka hoʻokuʻu ʻana i ka hoʻāʻo.
⚠️ ʻŌlelo Aʻo: ʻAʻole hōʻoia ʻia kahi ʻāpana paʻa hoʻokahi i ke kaʻina. Me ka ʻole o nā ʻāpana ʻāpana i ke koena i hoʻololi ʻia, hiki i ka epimer a i ʻole ka hui hewa ʻana ma kahi kūlana kokoke ke hele i ka kikoʻī like.
Kahi e hele ana ka pahu paahana
Me kēlā mau kuhi hewa i hoʻopau ʻia, ʻo ke kuhikuhi o ka huakaʻi e pili ana i ka hoʻohana ʻana i nā code hou aʻe i ka manawa hoʻokahi. Ma kahi o ka hana mua i hilinaʻi ai ma luna o hoʻokahi pair orthogonal, Ua hōʻike ʻia nā ʻōnaehana hou e hiki ke hana i nā hui like orthogonal i hoʻohana pū ʻia i loko o ka cell hoʻokahi, ʻo ia ka mea e hana ai i ka hoʻohui ʻia ʻana o nā wahi he nui o nā waikawa amino noncanonical like ʻole he koho hoʻolālā ma mua o kahi hoʻokolohua noʻonoʻo..
ʻO ka hoʻololi ʻelua ʻo ke kūkulu hale. Ua neʻe ka hoihoi i nā ʻōnaehana me ka ʻole o ka cell-free a me ka extract-based e pale ai i ka hoʻololi mau ʻana o ka genome host, e hoʻopōkole ana i ka pōʻai ma waena o ka hoʻolālā ʻana i kahi kūkulu a me ka hoʻāʻo ʻana. Me kēlā, ʻO ka hana codon ʻehā-nucleotide e hoʻolōʻihi i ka wahi codon i loaʻa ma mua o ka maʻamau 64, ka hoʻonui ʻana i ka lumi i loaʻa no ka hoʻonohonoho hou ʻana.
ʻAʻole hoʻololi ʻia ka ʻōlelo hōʻoia: ʻO ka maikaʻi o ka hoʻopaʻa ʻana e noho ncAA- a me ke kaʻina-context-dependent, ʻAʻole kūpono kēlā me kēia ʻakika amino noncanonical i kēlā me kēia ala. ʻO ia ke kumu o ka loiloi loiloi ma ʻO nā Peptides Synthetic keia alakai, ma mua o kekahi paʻa a i ʻole ka paepae, ʻo ia ka ʻāpana kūpono e mālama: E hoʻololi mau nā code genetic i hoʻonui ʻia no ka hoʻolālā peptide maʻamau, akā, ʻo nā mana e hōʻoiaʻiʻo i ka mea āu i kūkulu ai, ʻaʻole ia.
Nā ʻanuʻu aʻe
E lawe mai i kahi kaʻina kikoʻī a me kahi koi kūpaʻa kikoʻī i ke kamaʻilio ʻenehana mua e pili ana i nā code genetic i hoʻonui ʻia no ka hoʻolālā peptide maʻamau, ʻaʻole he nīnau nui. Hoʻololi ka papa helu loiloi ma lalo nei i nā ʻāpana ʻehā o kēia alakaʻi i mau nīnau e hiki i kahi hoa ke pane me ka pale ʻole.:
-
ʻO ka hui ʻo orthogonal, a he aha ka hana hoʻopau ʻana i ʻike ʻia no ia ma kāu hōʻike hoʻokipa?
-
ʻO ka hoʻolālā codon: hoʻopaʻa amber, ka hoʻihoʻi ʻana i ka sense-codon, a i ʻole he quadruplet codon?
-
ʻO ke ala hea no kēia kaʻina: SPSS, ka hoʻohui ʻole ʻana o ke kelepona, aiʻole ka fermentation, a no ke aha kēlā?
-
ʻO ke kemika conjugation, a noho ʻokoʻa i nā koena i loko o ke kaulahao?
-
ʻO wai o nā mana analytical fidelity sequence ʻelima i holo i kēlā me kēia hailona, a he aha nā ʻae ʻae?
He hoa hiki ke pane i na mea elima, a e haʻi maopopo i kahi e holo ʻole ai kahi ncAA a i ʻole ala, ʻoi aku ka waiwai ma mua o ka haʻahaʻa haʻahaʻa. Kākoʻo ʻo MOL Changes i kēia ʻano kamaʻilio hoʻolālā-i-QC ma waena 300+ hui hana, SPPS a me ka fermentation microbial, pālākiō mg-a-kg, a me HPLC/MS a me sterility QC ma lalo o ka Papa 100 kūlana lumi hoʻomaʻemaʻe.
Hōʻike: ʻO MOL Changes ke kākoʻo o kēia alakaʻi. Hōʻike ʻia ke kāʻei a me ka loiloi loiloi ma luna no ka noiʻi a me nā kumu hoʻohālikelike. E pili ana
Nīnau pinepine
He aha ke code genetic i hoʻonui ʻia?
ʻO ke code genetic i hoʻonui ʻia he ʻōnaehana unuhi kahi i hoʻonohonoho hou ʻia ai hoʻokahi a ʻoi aku paha nā codon e kuhikuhi i kahi amino acid noncanonical ma kahi o ka mea maʻamau.. Kuhi ʻia ka hoʻonohonoho hou ʻana ma mua o ka honua: Hoʻokomo ʻia kahi tRNA orthogonal a me kāna hui aminoacyl-tRNA synthetase no laila ke hoʻopiʻi ka synthetase i kāna tRNA cognate engineered., me ka waiho ʻole ʻana i ka mīkini unuhi ponoʻī a ka mea hoʻokipa. I loko o ka pahu 64-codon maʻamau, e waiho ana i kahi e hoʻokomo ai i kahi hana kemika hou ma kahi i koho ʻia me ke kākau ʻole ʻana i ke koena o ka proteome.
ʻEhia mau ʻakika amino noncanonical hiki ke hoʻopili ʻia?
A 2025 Hoʻopau ka loiloi loiloi i ka helu o nā ʻakika amino noncanonical genetically encodable 300, ʻoiai e wehewehe ana kēlā kiʻi i ka pahu hāmeʻa kumulative o ke kahua ma mua o ka mea e hiki ai i kekahi ʻōnaehana ke hāʻawi. ʻOi aku ka liʻiliʻi o ka helu hana, no ka mea, pono kēlā me kēia ncAA i kahi hui orthogonal kūpono a me kahi pūʻali e ʻae i ka reassignment. E mālama i ka helu poʻomanaʻo ma ke ʻano he palena luna ma luna o ka mea i hōʻike ʻia ma kahi, ʻaʻole ma ke ʻano he papa kuhikuhi hiki iā ʻoe ke kauoha mai.
He aha ka ʻokoʻa ma waena o ka hoʻopau ʻana i ka amber a me ka reassignment sense-codon?
Heluhelu ʻo Amber suppression ma ka UAG stop codon a hoʻokūkū pololei me ka mea hoʻokuʻu 1, no laila, ʻoki ʻia kāna ʻano hana hemahema. Hoʻololi ka Sense-codon reassignment i kahi codon e hoʻopili maʻamau i ke koena maʻamau, no laila, ʻo kona ʻano hemahema he heluna kanaka huikau: hiki i ka hua ke noho kiʻekiʻe ke hāʻule ka maʻemaʻe, no ka mea, ua hoʻokomo pū ʻia ke koena ʻano hihiu me ka ncAA. Hoʻoholo kēlā ʻokoʻa i nā mana e pono ai ʻoe, ʻoiai ʻo ka ʻoki ʻana i hōʻike ʻia i loko o ka nui paʻa ʻoiai ʻaʻole i loaʻa ka unuhi hewa.
Hiki ke hana ʻia nā ʻakika amino noncanonical e SPPS ma mua o ka hoʻonui ʻana i ke code genetic?
nā ʻakika β-amino, a,nā koena i hoʻololi ʻia, ʻO nā loulou depsipeptide a me nā koena N-methylated he mea maʻamau wale nō e hiki ke loaʻa ma ka solid-phase synthesis a i ʻole in vitro chemistry., no ka mea, ʻaʻole e ʻae ka ribosome iā lākou ma ke ʻano he substrate. He haiki ka papa genetically encodable: nā hoʻololi kaulahao ʻaoʻao i kūkulu ʻia ma luna o ka iwi kuamoʻo α-amino-acid. ʻO Selenocysteine ka mea kūlohelohe, i hoʻopaʻa ʻia ma o kāna mīkini hoʻolaʻa ponoʻī ma mua o kahi pālua i hana ʻia. Hana ʻia ʻo Peptide
Pehea ʻoe e hōʻoia ai ua hoʻokomo ʻia kahi ʻakika amino noncanonical ma ke kahua i manaʻo ʻia?
Pono ka hōʻoia ʻana i nā ʻāpana ʻāpana kikoʻī a me ka hoʻonohonoho ʻana i nā ʻāpana ʻāpana i hoʻopaʻa ʻia i ke koena i hoʻololi ʻia., maʻamau e LC-MS/MS, hui pū me ka helu o ka hoʻohui ʻana a me ka mana epimer e kūʻē i kahi kuhikuhi synthetic. ʻAʻole lawa ka nuipaʻa paʻa wale no ka mea ʻaʻole hiki iā ia ke hoʻokaʻawale i ka pae i manaʻo ʻia mai kahi isomer kūlana a i ʻole kahi ʻano holoi holoi o ka nui like.. ʻO nā ʻāpana ʻāpana ka mea e hoʻokaʻawale i ke koena; haʻi wale ka nuipa iā ʻoe i kekahi mea i loli.
Hiki ke hoʻohui ʻia nā ʻakika amino noncanonical i ʻoi aku ma mua o hoʻokahi kahua?
ʻAe, akā ʻo ka hoʻohui ʻana i nā pūnaewele he nui e hoʻonui i ka kaumaha analytical ma mua o ka hana hou ʻana i kahi kahe hana hoʻokahi.. Hoʻohui kēlā me kēia kūlana hou i kāna hana hoʻopau a hoʻihoʻi hou paha, a hāʻule ka hapa o ka huahana e lawe ana i ka ncAA ma kēlā me kēia kahua i manaʻo ʻia i ka wā e hōʻiliʻili ai nā kūlana, no laila, lilo ka heluna kanaka i mahele o nā ʻano mea i hoʻololi hapa ʻia. Pono ʻoe e hoʻoholo i mua inā hoʻoholo ka assay i kēlā māhele, no ka mea, ʻaʻole e hōʻike koke ʻia kahi ala i hoʻopaʻa ʻia no kahi pūnaewele ʻehā.
Hiki ke hoʻonui ʻia ka hoʻonui code genetic no ka hana ʻana i ka peptide pae lapaʻau?
Pili ka scalability i ke ala āu e koho ai, a ʻokoʻa nā ala ʻelua. Ua hōʻike ʻia ka hoʻokumu ʻana o ka protein cell-free synthesis i nā pae i hōʻike mua ʻia ma kēia ʻatikala, akā, hele mai kēlā mau helu mai nā ʻōnaehana hoʻokolohua i wehewehe ʻia a ʻaʻole e hoʻololi maʻalahi i kahi kaʻina GMP. ʻOi aku ka manaʻo o nā unahi paʻa-phase synthesis no nā kaʻina pōkole akā ʻaʻole hiki ke hiki i nā koena he SPPS wale nō.. No ka hana ma'i, ʻAʻole ka nīnau kūpono inā ʻaʻole ke kaulike kemika akā inā hiki i kāu pūʻolo analytical ke hōʻoia i ka hilinaʻi o ka nui-a-lot ma kēlā pālākiō..
Ka hopena
ʻO ka hoʻolālā codon āu e koho ai e hoʻoholo i ke ʻano hemahema āu i hoʻoili ai, no laila, pono e kuhikuhi ʻia ka pūʻolo mana e hōʻoiaʻiʻo ana i ka ʻoiaʻiʻo ma mua o ka hailona mua, aole mahope. ʻO ia ka pae e holo nei ma kēia alakaʻi: expanded genetic codes for custom peptide design are an evaluation problem before they are a synthesis problem.
The four decisions a partner must be able to defend in writing are the noncanonical amino acid and its suppression behavior in your sequence context, the library design and how it constrains the route, the conjugation chemistry and what it leaves intact, and the analytical acceptance criteria with their methods and limits. Each one narrows the next.
The direction of travel is toward mutually orthogonal pairs used together, cell-free and extract-based systems that leave the host genome untouched, and four-nucleotide codons that extend the available codon space past the standard 64. The honest caveat is that suppression efficiency stays dependent on the ncAA and the surrounding sequence, a ʻaʻole kūpono kēlā me kēia ncAA me kēlā me kēia ala.
E hoʻohana i ka papa inoa ma Next Steps i kumu no kāu kamaʻilio ʻenehana mua.
No ka mea kākau: [Ka inoa mea kākau], [palapala hōʻoia], kākau ma ka hoʻolālā peptide a me ka hoʻolālā hoʻokele analytical no nā Hoʻololi MOL.
Hōʻike: Hāʻawi ʻo MOL Changes i ka hoʻolālā peptide, synthesis and analytical services, me nā mea hiki i kūkākūkā ʻia ma kēia alakaʻi.
